VF
CNTB icon

Virtu Financial’s Connect Biopharma Holdings CNTB Stock Holding History

Virtu Financial’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,914
Closed -$44K – 1696
2026
Q1 		$44K Buy
+16,914
New +$44.1K ﹤0.01% 1307
2022
Q3 		– Sell
-16,658
Closed -$14K – 1790
2022
Q2 		$14K Buy
+16,658
New +$24.5K ﹤0.01% 1385

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Virtu Financial's CNTB Position: Q2 2026 in Review

Virtu Financial sold out of Connect Biopharma Holdings (CNTB) in Q2 2026, closing a stake of 16,914 shares — an estimated $44K sold.

Virtu Financial first reported a position in CNTB in Q2 2022 and held it in 2 quarters. The position peaked at $44K in Q1 2026. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Virtu Financial reported no remaining Connect Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 16,914 Connect Biopharma Holdings shares in Q2 2026, an estimated $44K.
  • Virtu Financial first reported a position in Connect Biopharma Holdings in Q2 2022 and held it in 2 quarters.
  • Virtu Financial's Connect Biopharma Holdings position peaked at $44K in Q1 2026.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.